Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

Treatment of Chronic Hepatitis C Virus Infection in Older Adults

Kim JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Well-differentiated Hepatocellular Carcinoma

Han JK, Kim SJ, Kim SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intrahepatic Cholangiocarcinoma associated with Hepatolithiasis

Jeen YM, Jin SY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Microbiological Characteristics of Spontaneous Bacterial Peritonitis in Korea

Heo J, Um SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection

Jeong SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Activated Hepatic Stellate Cells in Liver Fibrosis, Portal Hypertension and Cancer Angiogenesis

Lee JS, Kim JH

Although hepatic stellate cells, which are liver specific pericytes, have been recognized within the vasculature of the sinusoid for more than one hundred years, the biology and function of these...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin

Kim YH, Han WS, Lee SJ, Oh SN, Choi DW, Byun KS, Yeon JE

There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Hepatic Abscess Caused by Toxocara

Jung JK, Jung JT, Lee CH, Kim EY, Kwon JG, Kim BS

Toxocariasis is a helminozoonosis caused by the infection of a human host by the larva of Toxocara canis and Toxocara catis, which are common nematodes in dogs and cats, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Alfuzosin-induced Acute Liver Injury

Kim SY, Kim BH, Dong SH, Kim HJ, Chang YW, Chang R, Kim YW

We describe a 56-year-old man who developed an acute liver injury after taking alfuzosin for 1 month to control his newly diagnosed benign prostatic hypertrophy (BPH). There was no history...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Molecular Mechanisms of Hepatitis B Virus-associated Hepatocellular Carcinoma

Park NH, Chung YH

Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. The hepatitis B virus (HBV) replicates non-cytopathically in hepatocytes, and most of the liver injury associated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Recent IgG Anti-HAV Prevalence between Two Hospitals in Seoul and Gyeonggi area

Kim TY, Sohn JH, Ahn SB, Son BK, Lee HL, Eun CS, Jeon YC, Han DS

BACKGROUND/AIMS: Recently, the incidence of acute hepatitis A has increased nationwide and is related to the low rate of IgG anti-HAV. This study compared the prevalence of IgG anti-HAV...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B

Kim IH, Kim SH, Kim HC, Shin KD, Kim SW, Lee SO, Lee ST, Kim DG

BACKGROUND/AIMS: Adefovir dipivoxil (ADV) resistance in patients with lamivudine-resistant chronic hepatitis B is not well understood. This study examined the initial virologic response (IVR) to ADV, the rate of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients

Jung EU, Park JH, Pae KI, Kang SW, Park SJ, Jee SR, Park ET, Lee YJ, Lee SH, Seol SY

BACKGROUND/AIMS: The standard treatment for chronic hepatitis C patients infected with HCV genotype-2 is a combination of pegylated interferon alfa and ribavirin over a 24 week period. It is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in the Profiles of Causative Agents and Antibiotic Resistance Rate for Spontaneous Bacterial Peritonitis: an Analysis of Cultured Microorganisms in Recent 12 Years

Park MK, Lee JH, Byun YH, Lee HI, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Rhee JC

BACKGROUNDS/AIMS: The causative agents for spontaneous bacterial peritonitis (SBP) and antibiotic resistance rate vary according to the regions and time. This study evaluated the recent changes in the profiles...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of Caveolin in Hepatocellular Carcinoma: Association with Unpaired Artery Formation and Radiologic Findings

Choi HN, Kim KR, Park HS, Jang KY, Kang MJ, Lee DG, Kim YK, Cho BH, Cha EJ, Moon WS

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is becoming one of the common malignant tumors worldwide, and it is characterized by its high vascularity. Caveolin is the major structural protein in caveolae,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Transarterial Chemolipiodolization with or without 3-Dimensional Conformal Radiotherapy for Huge HCC with Portal Vein Tumor Thrombosis

You CR, Jang JW, Kang SH, Bae SH, Choi JY, Yoon SK, Choi IB, Lee DH, Chun HJ, Choi BG

BACKGROUND/AIMS: The treatment efficacy for advanced hepatocellular carcinoma is poor. This study examined the efficacy and toxicity of 3-dimensional conformal radiotherapy (3D-CRT) in combination with transarterial chemolipiodolization (TACL) for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Features and Treatment Outcome of Advanced Hepatocellular Carcinoma with Inferior Vena Caval Invasion or Atrial Tumor Thrombus

Kim SU, Kim YR, Kim DY, Kim JK, Lee HW, Kim BK, Han KH, Chon CY, Moon YM, Ahn SH

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) with an extension to the inferior vena cava (IVC) or right atrium is uncommon, and its prognosis remains unclear due to the few case reports....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr